Log In
BCIQ
Print this Print this
 

ECCS-50

  Manage Alerts
Collapse Summary General Information
Company Cytori Therapeutics Inc.
DescriptionAutologous adipose tissue-derived stromal vascular fraction cells separated and concentrated using Cytori's Celution 800 System
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Stem cell
Latest Stage of DevelopmentPhase III
Standard IndicationScleroderma
Indication DetailsTreat scleroderma; Treat scleroderma-related hand dysfunction; Treat systemic sclerosis with hand disability
Regulatory Designation EU - Orphan Drug (Treat scleroderma);
EU - Orphan Drug (Treat systemic sclerosis with hand disability)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today